FDA OKs Combo Therapy for First-Line Mesothelioma Therapy

FDA OKs Combo Therapy for First-Line Mesothelioma Therapy

Uncategorized

Combination nivolumab and ipilimumab has now been authorized as first-line therapy in mesothelioma and possibly a new typical of care. FDA Approvals
Study More

Leave a Reply

Your email address will not be published. Required fields are marked *